Histological findings in patients with suspected mediastinal lymphoma relapse according to positive positron emission tomography scan during follow-up: a large retrospective analysis in 96 patients.


Journal

Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 2 3 2019
medline: 22 8 2020
entrez: 2 3 2019
Statut: ppublish

Résumé

Residual masses in patients with mediastinal lymphoma may be positron emission tomography (PET) positive during follow-up also in cases of complete response. The aim of this retrospective study is to verify the reliability of mediastinal PET-positive findings in suggesting disease relapse or progression during follow-up by histological verification. From January 2002 to March 2016, 96 patients with mediastinal lymphoma underwent PET follow-up after front-line treatment. A surgical biopsy was performed to confirm the suspected relapse (for a total of 113 procedures). A lymphoma relapse was diagnosed in 66/102 successful procedures (64.7%). Diagnosis at relapse was concordant with the initial diagnosis in all but 3 cases. Standardized uptake value was significantly higher among patients with relapse than among those who remained in remission (10 versus 5,

Identifiants

pubmed: 30821538
doi: 10.1080/10428194.2019.1581931
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2247-2254

Auteurs

Alessandro Broccoli (A)

Institute of Hematology "L. e A. Seràgnoli", University of Bologna , Bologna , Italy.

Sergio Nicola Forti Parri (SN)

Thoracic Surgery Unit, Maggiore-Bellaria Hospital , Bologna , Italy.

Cinzia Pellegrini (C)

Institute of Hematology "L. e A. Seràgnoli", University of Bologna , Bologna , Italy.

Beatrice Casadei (B)

Institute of Hematology "L. e A. Seràgnoli", University of Bologna , Bologna , Italy.

Barbara Bonfanti (B)

Thoracic Surgery Unit, Maggiore-Bellaria Hospital , Bologna , Italy.

Luca Bertolaccini (L)

Thoracic Surgery Unit, Maggiore-Bellaria Hospital , Bologna , Italy.

Claudio Agostinelli (C)

Hematopathology Unit, University of Bologna , Bologna , Italy.

Maurizio Boaron (M)

Thoracic Surgery Unit, Maggiore-Bellaria Hospital , Bologna , Italy.

Stefano Fanti (S)

Nuclear Medicine, Sant'Orsola-Malpighi Hospital, University of Bologna , Bologna , Italy.

Cristina Nanni (C)

Nuclear Medicine, Sant'Orsola-Malpighi Hospital, University of Bologna , Bologna , Italy.

Lisa Argnani (L)

Institute of Hematology "L. e A. Seràgnoli", University of Bologna , Bologna , Italy.

Pier Luigi Zinzani (PL)

Institute of Hematology "L. e A. Seràgnoli", University of Bologna , Bologna , Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH